Treatment With Stereotactic Ablative Radiotherapy for Up to 5 Oligometastases in Patients With Cancer: Primary Toxic Effect Results of the Nonrandomized Phase 2 SABR-5 Clinical Trial.Robert Olson,Will Jiang,Mitchell Liu,Alanah Bergman,Devin Schellenberg,Benjamin Mou,Abraham Alexander,Hannah Carolan,Fred Hsu,Stacy Miller,Siavash Atrchian,Elisa Chan,Clement Ho,Islam Mohamed,Angela Lin,Tanya Berrang,Andrew Bang,Nick Chng,Quinn Matthews,Sarah Baker,Vicky Huang,Ante Mestrovic,Derek Hyde,Chad Lund,Howard Pai,Boris Valev,Shilo Lefresene,Scott TyldesleyJAMA oncology（2022）引用 10|浏览9暂无评分摘要ClinicalTrials.gov Identifier: NCT02933242.更多查看译文AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
